LCDActive
Urinary Biomarkers for Chronic Pain Management
L39616
Effective: October 8, 2023
Updated: December 31, 2025
Policy Summary
This contractor does not cover urinary biomarker laboratory tests for chronic pain, including laboratory-developed panels such as the Foundation Pain Index. The policy cites lack of specific validated biomarkers for chronic pain and insufficient evidence of clinical utility; the referenced tests are LDTs and are not FDA-regulated.
Coverage Criteria Preview
Key requirements from the full policy
"Urinary biomarker laboratory tests for chronic pain are non-covered by this contractor."
Sign up to see full coverage criteria, indications, and limitations.
Covered Medical Codes